Compare ARK Genomic Revolution ETF (ARKG) vs SOLAI Limited (SLAI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs SOLAI Limited — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while SOLAI Limited trades at $3.34 (market cap $15.52M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, SOLAI Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | SLAI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $30.66 |
52-Week Low | $23.09 | $2.74 |
Market Cap | — | $15.52M |
Enterprise Value | — | $15.16M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SLAI trades at $3.34, up 7.05% today, but technical indicators signal a bearish trend with support at $3. The company reported a net loss of $33.88M in 2025, with negative profit margins and ROE. Recent news includes a reverse stock split and a going-private proposal, while the sole analyst coverage is a Hold rating.
The outlook remains highly speculative due to persistent losses and NYSE listing concerns. Risks include financial instability and execution challenges in AI infrastructure. Upside depends on successful acquisitions and product launches, but the stock is suitable only for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About SOLAI Limited
SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.
Read more on SLAI →
